Related Experiment Videos
Is adrenaline released by sympathetic nerves in man?
M Esler1, G Eisenhofer, J Chin
1Alfred Baker Medical Unit, Alfred Hospital, Melbourne, Australia.
This study investigated whether adrenaline is released from sympathetic nerves in humans. Using radiotracer methods, researchers measured adrenaline and noradrenaline release in the heart, lungs, liver, and kidneys. In healthy individuals at rest, no adrenaline release was detected from these organs. However, adrenaline was found in the renal vein, likely from the adrenal glands. During exercise, adrenaline release remained low compared to noradrenaline. In patients with heart failure and phaeochromocytoma, adrenaline was clearly released from non-adrenal sources. These findings suggest that adrenaline may be released from sympathetic nerves in certain conditions. Whether this release contributes to hypertension remains to be determined.
Area of Science:
- Neuroendocrinology and cardiovascular physiology
- Sympathetic nervous system function in humans
- Adrenaline release mechanisms in metabolic medicine
Background:
Prior research has shown that adrenaline is primarily secreted by the adrenal medulla. However, the role of sympathetic nerve endings in adrenaline release remains unclear. This gap motivated a study to investigate whether adrenaline can be released from non-adrenal sources in humans. It was already known that noradrenaline is released by sympathetic nerves, but the contribution of adrenaline is uncertain. No prior work had resolved whether adrenaline functions as a cotransmitter in sympathetic nerve terminals. This uncertainty is especially relevant in conditions like hypertension and heart failure. The study aimed to address this by measuring regional adrenaline release in specific organs. These measurements could clarify the physiological and pathological roles of adrenaline beyond adrenal secretion.
Purpose Of The Study:
The study aimed to determine if adrenaline is released from sympathetic nerve endings in humans. This was done to test a theory about essential hypertension that suggests adrenaline may act as a cotransmitter. The researchers focused on measuring adrenaline release in the heart, lungs, and liver. They also examined adrenaline release in the renal vein and during physical and mental stress. The goal was to distinguish between adrenal and non-adrenal sources of adrenaline. The study sought to clarify whether adrenaline is released in response to sympathetic activation. This could help explain how adrenaline might influence cardiovascular responses. The findings could provide insights into the mechanisms of hypertension and heart failure.
Main Methods:
The researchers used radiotracer methods to measure adrenaline and noradrenaline release in specific regions of the body. These methods allowed them to track the release of these catecholamines into plasma. They focused on the heart, lungs, liver, and kidneys in healthy individuals. The study also included patients with heart failure and phaeochromocytoma. Mental challenge and isometric exercise were used to activate sympathetic nerves. Supine bicycle exercise was employed to increase sympathetic outflow. Adrenaline release was measured in the right renal vein and compared to other regions. The radiotracer data provided quantitative estimates of adrenaline release rates.
Main Results:
In healthy resting individuals, no adrenaline release was detected from the heart, lungs, or liver. Adrenaline was found in the right renal vein, but the source was likely the adrenal medulla. During mental stress and isometric exercise, cardiac adrenaline release remained undetectable. Supine bicycle exercise increased noradrenaline release 10-30 fold, but adrenaline release averaged only 2.36 ng/min. In patients with heart failure, adrenaline release was clearly detectable from non-adrenal sources. Those with phaeochromocytoma also showed regional adrenaline release at rest. These findings suggest that adrenaline can be released from sympathetic nerves in certain conditions. However, the functional significance of this release remains to be fully determined.
Conclusions:
The study found that adrenaline is released from non-adrenal sources in humans, particularly during exercise and in certain disease states. This release likely occurs from sympathetic nerve endings rather than the adrenal glands. In healthy individuals at rest, no adrenaline release was observed from the heart, lungs, or liver. Adrenaline was detected in the renal vein, but the source was suspected to be adrenal. During exercise, adrenaline release remained low compared to noradrenaline. In patients with heart failure and phaeochromocytoma, adrenaline release was clearly evident. The authors suggest that this release could influence cardiovascular responses. Whether this release contributes to hypertension remains to be tested.
Frequently Asked Questions
The study found that adrenaline is released from non-adrenal sources in humans during exercise and in certain diseases.
They used radiotracer methods to track adrenaline and noradrenaline release into plasma in specific organs.
Because adrenaline was detected there, but the source was suspected to be the adrenal medulla rather than sympathetic nerves.
It increased noradrenaline release 10-30 fold but only raised adrenaline release to an average of 2.36 ng/min.
In patients with heart failure and phaeochromocytoma, regional adrenaline release was clearly detectable.
The authors suggest that adrenaline release from sympathetic nerves may contribute to hypertension, but this remains to be tested.